C-B2-05: Screening Colonoscopy: Benefits, Barriers and Conflicting Information

Kathleen M. Mazor, Meghan J. Mooradian, M. Costanza, Terry S. Field, Bridget Gaglio, Sarah E. Greene, Peng Han, B. Robinson, D. Roblin, J. Wagner, Anne WilliamsClinical 2011 · DOI

Abstract

what sort of cancer a PSA test screened for scored lower than those who did (p<.05). Overall, 35% of men had read or been given conflicting information about PSA testing; these men were more likely to report mixed feelings about PSA testing, would be less likely to find a normal result reassuring, and were less likely to believe that PSA testing reduces chances of dying from prostate cancer (p<.05). Conclusions: Many men in this study were unfamiliar with PSA testing. Most believed that PSA testing would reduce their chances of dying from prostate cancer, and were not aware of conflicting information about PSA testing. Patient education about PSA testing is needed.
BibTeX
@inproceedings{mazor2011c,
  author = {Kathleen M. Mazor and Meghan J. Mooradian and M. Costanza and Terry S. Field and Bridget Gaglio and Sarah E. Greene and Peng Han and B. Robinson and D. Roblin and J. Wagner and Anne Williams},
  title = {{C-B2-05: Screening Colonoscopy: Benefits, Barriers and Conflicting Information}},
  booktitle = {Clinical},
  year = {2011},
  doi = {10.3121/cmr.2011.1020.c-b2-05},
}

Loading related content...

Figure